Chalkophomycin Biosynthesis Revealing Unique Enzyme Architecture for a Hybrid Nonribosomal Peptide Synthetase and Polyketide Synthase
Molecules · 2024
DOI: 10.3390/molecules29091982 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Long Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China. Hauptthemen laut MEDLINE: Multigene Family, Streptomyces, Polyketide Synthases, Peptide Synthases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hunan Provincial Natural Science Foundation of China, Chinese Ministry of Education 111 Project.
Abstract (Originalsprache)
Chalkophomycin is a novel chalkophore with antibiotic activities isolated from Streptomyces sp. CB00271, while its potential in studying cellular copper homeostasis makes it an important probe and drug lead. The constellation of N-hydroxylpyrrole, 2H-oxazoline, diazeniumdiolate, and methoxypyrrolinone functional groups into one compact molecular architecture capable of coordinating cupric ions draws interest to unprecedented enzymology responsible for chalkophomycin biosynthesis. To elucidate the biosynthetic machinery for chalkophomycin production, the chm biosynthetic gene cluster from S. sp. CB00271 was identified, and its involvement in chalkophomycin biosynthesis was confirmed by gene replacement. The chm cluster was localized to a ~31 kb DNA region, consisting of 19 open reading frames that encode five nonribosomal peptide synthetases (ChmHIJLO), one modular polyketide synthase (ChmP), six tailoring enzymes (ChmFGMNQR), two regulatory proteins (ChmAB), and four resistance proteins (ChmA′CDE). A model for chalkophomycin biosynthesis is proposed based on functional assignments from sequence analysis and structure modelling, and is further supported by analogy to over 100 chm-type gene clusters in public databases. Our studies thus set the stage to fully investigate chalkophomycin biosynthesis and to engineer chalkophomycin analogues through a synthetic biology approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
- Hefei Comprehensive National Science Center, Institute of Health and Medicine, Hefei 230093, China.
- Xiangya International Academy of Translational Medicine, Central South University, Changsha 410013, China.
- Department of Pharmacy, The Affiliated Nanhua Hospital, Hengyang Medical School, University of South China, Hengyang 421001, China.
- College of Pharmacy, Hunan Vocational College of Science and Technology, Changsha 410004, China.
- Hunan Engineering Research Center of Combinatorial Biosynthesis and Natural Product Drug Discovery, Changsha 410011, China.
ORCID-Profile: Liwei Yi
Förderung
- National Natural Science Foundation of China
- Hunan Provincial Natural Science Foundation of China
- Chinese Ministry of Education 111 Project
Zitieren
APA
Yang, L., Yi, L., Gong, B., Chen, L., Li, M., Zhu, X., Duan, Y., & Huang, Y. (2024). Chalkophomycin Biosynthesis Revealing Unique Enzyme Architecture for a Hybrid Nonribosomal Peptide Synthetase and Polyketide Synthase. Molecules. https://doi.org/10.3390/molecules29091982
Vancouver
Yang L, Yi L, Gong B, Chen L, Li M, Zhu X, et al. Chalkophomycin Biosynthesis Revealing Unique Enzyme Architecture for a Hybrid Nonribosomal Peptide Synthetase and Polyketide Synthase. Molecules. 2024. doi:10.3390/molecules29091982
BibTeX
@article{Yang2024,
author = {Yang, Long and Yi, Liwei and Gong, Bang and Chen, Lili and Li, Miao and Zhu, Xiangcheng and Duan, Yanwen and Huang, Yong},
title = {Chalkophomycin Biosynthesis Revealing Unique Enzyme Architecture for a Hybrid Nonribosomal Peptide Synthetase and Polyketide Synthase},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29091982}
}
EUVIMED